Abstract
Elastin-specific medial vascular calcification, termed “Monckeberg’s sclerosis,” has been recognized as a major risk factor for various cardiovascular events. We hypothesize that chelating agents, such as disodium ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid (DTPA), and sodium thiosulfate (STS) might reverse elastin calcification by directly removing calcium from calcified tissues into soluble calcium complexes. We assessed the chelating ability of EDTA, DTPA, and STS on removal of calcium from hydroxyapatite (HA) powder, calcified porcine aortic elastin, and calcified human aorta in vitro. We show that both EDTA and DTPA could effectively remove calcium from HA and calcified tissues, while STS was not effective. The tissue architecture was not altered during chelation. In the animal model of aortic elastin-specific calcification, we further show that local periadventitial delivery of EDTA loaded in to poly(lactic-co-glycolic acid) nanoparticles regressed elastin-specific calcification in the aorta. Collectively, the data indicate that elastin-specific medial vascular calcification could be reversed by chelating agents.
Similar content being viewed by others
Abbreviations
- EDTA:
-
Disodium ethylene diamine tetraacetic acid
- DTPA:
-
Diethylene triamine pentaacetic acid
- STS:
-
Sodium thiosulfate
- Ca:
-
Calcium
- P:
-
Phosphorus
- HA:
-
Hydroxyapatite
- PLGA:
-
Poly(lactic-co-glycolic acid)
- CaCl2 :
-
Calcium chloride
- CAC:
-
Coronary artery calcification
- MAC:
-
Medial arterial calcification
References
Liu Y, Zhou YB, Zhang GG, Cai Y, Duan XH, Teng X, Song JQ, Shi Y, Tang CS, Yin XH, Qi YF (2010) Cortistatin attenuates vascular calcification in rats. Regul Pept 159:35–43
Kapustin A, Shanahan CM (2009) Targeting vascular calcification: softening-up a hard target. Curr Opin Pharmacol 9:84–89
Shanahan CM, Cary NRB, Salisbury JR, Proudfoot D, Weissberg PL, Edmonds ME (1999) Medial localization of mineralization-regulating proteins in association with Mönckeberg’s sclerosis: evidence for smooth muscle cell–mediated vascular calcification. Circulation 100:2168–2176
Lamas GA, Hussein SJ (2006) EDTA chelation therapy meets evidence-based medicine. Complement Ther Clin Pract 12:213–215
Jackson G (2008) Chelation therapy is TACT-less. Int J Clin Pract 62:1821–1822
Atwood KC, Woeckner E, Baratz RS, Sampson WI (2008) Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned. Medscape J Med 10:115
Fraker TD et al (2007) 2007 Chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina. Circulation 116:2762–2772
Lamas GA et al (2013) Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA 309:1241–1250
Partridge S, Keeley F (1974) Age related and atherosclerotic changes in aortic elastin. In: Arterial mesenchyme and arteriosclerosis. Springer, New York, pp 173–191
Lee JS, Basalyga DM, Simionescu A, Isenburg JC, Simionescu DT, Vyavahare NR (2006) Elastin calcification in the rat subdermal model is accompanied by up-regulation of degradative and osteogenic cellular responses. Am J Pathol 168:490–498
Vyavahare N, Ogle M, Schoen FJ, Levy RJ (1999) Elastin calcification and its prevention with aluminum chloride pretreatment. Am J Pathol 155:973–982
Labhasetwar V, Song C, Levy RJ (1997) Nanoparticle drug delivery system for restenosis. Adv Drug Deliv Rev 24:63–85
Cagnasso CE, López LB, Rodríguez VG, Valencia ME (2007) Development and validation of a method for the determination of EDTA in non-alcoholic drinks by HPLC. J Food Composit Anal 20:248–251
Basalyga DM, Simionescu DT, Xiong W, Baxter BT, Starcher BC, Vyavahare NR (2004) Elastin degradation and calcification in an abdominal aorta injury model. Circulation 110:3480–3487
Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FJ, Farese S (2008) Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int 74:1444–1453
Basalyga DM, Simionescu DT, Xiong W, Baxter BT, Starcher BC, Vyavahare NR (2004) Elastin degradation and calcification in an abdominal aorta injury model: role of matrix metalloproteinases. Circulation 110:3480–3487
Pasch A, Schaffner T, Huynh-Do U, Frey BM, Frey FJ, Farese S (2008) Sodium thiosulfate prevents vascular calcifications in uremic rats. Kidney Int 74:1444–1453
Adirekkiat S, Sumethkul V, Ingsathit A, Domrongkitchaiporn S, Phakdeekitcharoen B, Kantachuvesiri S, Kitiyakara C, Klyprayong P, Disthabanchong S (2010) Sodium thiosulfate delays the progression of coronary artery calcification in haemodialysis patients. Nephrol Dial Transplant 25:1923–1929
Postnov AA, D’Haese PC, Neven E, Clerck NM, Persy VP (2009) Possibilities and limits of X-ray microtomography for in vivo and ex vivo detection of vascular calcifications. Int J Cardiovasc Imaging 25:615–624
Cavallotti C et al (2004) Experimental calcification of the aorta in rabbits: effects of chelating agents and glucagon. J Lab Anim Sci 31:215–219
Persy V, Postnov A, Neven E, Dams G, De Broe M, D’Haese P, De Clerck N (2006) High-resolution X-ray microtomography is a sensitive method to detect vascular calcification in living rats with chronic renal failure. Arterioscler Thromb Vasc Biol 26:2110–2116
Lamas GA, Goertz C, Boineau R, Mark DB, Rozema T, Nahin RL, Drisko JA, Lee KL (2012) Design of the Trial to Assess Chelation Therapy (TACT). Am Heart J 163:7–12
Guldager B, Brixen K, Jørgensen S, Nielsen H, Mosekilde L, Jelnes R (1993) Effects of intravenous EDTA treatment on serum parathyroid hormone (1–84) and biochemical markers of bone turnover. Dan Med Bull 40:627
Waters RS, Bryden NA, Patterson KY, Veillon C, Anderson RA (2001) EDTA chelation effects on urinary losses of cadmium, calcium, chromium, cobalt, copper, lead, magnesium, and zinc. Biol Trace Elem Res 83:207–221
Shroff RC, Shanahan CM (2007) Vascular calcification in patients with kidney disease: the vascular biology of calcification. Semin Dial 20:103–109
Acknowledgement
The authors thank Dr. Michael E. Ward at Greenville Hospital System for providing samples of calcified human aorta and Dr. Tim Cooper at Ortec (Piedmont, SC) for gifting the PLGA polymer. This work was partially supported by the National Institutes of Health (P20GM103444, R01HL061652) and the Hunter Endowment at Clemson University.
Conflict of interest
The authors have stated that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lei, Y., Grover, A., Sinha, A. et al. Efficacy of Reversal of Aortic Calcification by Chelating Agents. Calcif Tissue Int 93, 426–435 (2013). https://doi.org/10.1007/s00223-013-9780-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-013-9780-0